Ceregene's Series B Round

Ceregene raised a round of funding on June 07, 2004.

Ceregene is a San Diego-based biotechnology company focused on the development of nervous system growth factors (neurotrophic factors) as treatments for neurodegenerative and retinal disorders using g…

Articles about Ceregene's Series B Round: